Screening for Individual Susceptibility Factors to Immersion Pulmonary Edema

NCT ID: NCT05049889

Last Updated: 2022-09-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

63 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-08-17

Study Completion Date

2026-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Immersion Pulmonary Edema (IPE) is a relatively new form of hemodynamic pulmonary edema. The number of cases has been increasing over the last ten years and it has become the second most common cause of hospitalization for military divers, after decompression sickness. The pathophysiological mechanisms of IPE are not completely known. Its occurrence is linked to a combination of factors related to the environmental constraints of diving, as well as to the diver's equipment. The main external factors are increased hydrostatic pressure, cold, intense effort and emotional stress. The impact of internal factors is not known. At this time, no severe forms of IPE have been identified in the military. However, it is important to identify this pathology at an early stage, even if the signs appear minor, because the continuation of underwater activity can significantly worsen the clinical picture. The risk of recurrence (greater than 15%) could result in a severe or even lethal accident.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pulmonary Edema

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

The model includes 2 groups:

* 1 group of divers with a history of immersion pulmonary edema
* 1 group of matched divers without a history of immersion pulmonary edema
Primary Study Purpose

SCREENING

Blinding Strategy

SINGLE

Outcome Assessors
The investigator who will be in charge of the physiological examination will not know the subject's group.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

History of Immersion Pulmonary Edema

The participants will have 2 visits:

At visit 1 (Day 0), the participants will perform a terrestrial exercise, have a transthoracic cardiac ultrasound, a transthoracic pulmonary ultrasound and several blood samples will be collected.

At visit 2 (Day 7), the participants will perform a swimming exercise, have a transthoracic cardiac ultrasound, a transthoracic pulmonary ultrasound and several blood samples will be collected.

Group Type ACTIVE_COMPARATOR

Terrestrial exercise

Intervention Type OTHER

At visit 1 (Day 0), an exercise test will be performed (maximal incremental test), followed by a 30-minute submaximal exercise at constant load.

During this exercise, continuous data collection will be performed:

* Continuous 12-lead electrocardiogram
* Continuous monitoring of blood pressure and ventilation.

Swimming exercise

Intervention Type OTHER

At visit 2 (Day 7), the subjects will perform a swimming exercise in the experimental pool equipped with a turbine to create a counter-current. The water speed will be constant (4 min per 100 m, i.e. 1.5 km/h). The duration of the exercise will be 30 minutes. Each diver will breathe with the help of a snorkel.

During this exercise, continuous data collection will be performed:

* Continuous 12-lead electrocardiogram
* Continuous monitoring of blood pressure and ventilation.

Transthoracic cardiac ultrasound

Intervention Type DEVICE

The participants will have a transthoracic cardiac ultrasound to measure the dilatations of the cardiac cavities at visit 1 and 2.

Transthoracic pulmonary ultrasound

Intervention Type DEVICE

The participants will have a transthoracic pulmonary ultrasound to quantify the presence of signs of pulmonary vascular overload (comet tails) at visit 1 and 2.

Blood collection

Intervention Type BIOLOGICAL

Several blood samples will be collected at visit 1 and 2.

No history of Immersion Pulmonary Edema

The participants will have 2 visits:

At visit 1 (Day 0), the participants will perform a terrestrial exercise, have a transthoracic cardiac ultrasound, a transthoracic pulmonary ultrasound and several blood samples will be collected.

At visit 2 (Day 7), the participants will perform a swimming exercise, have a transthoracic cardiac ultrasound, a transthoracic pulmonary ultrasound and several blood samples will be collected.

Group Type ACTIVE_COMPARATOR

Terrestrial exercise

Intervention Type OTHER

At visit 1 (Day 0), an exercise test will be performed (maximal incremental test), followed by a 30-minute submaximal exercise at constant load.

During this exercise, continuous data collection will be performed:

* Continuous 12-lead electrocardiogram
* Continuous monitoring of blood pressure and ventilation.

Swimming exercise

Intervention Type OTHER

At visit 2 (Day 7), the subjects will perform a swimming exercise in the experimental pool equipped with a turbine to create a counter-current. The water speed will be constant (4 min per 100 m, i.e. 1.5 km/h). The duration of the exercise will be 30 minutes. Each diver will breathe with the help of a snorkel.

During this exercise, continuous data collection will be performed:

* Continuous 12-lead electrocardiogram
* Continuous monitoring of blood pressure and ventilation.

Transthoracic cardiac ultrasound

Intervention Type DEVICE

The participants will have a transthoracic cardiac ultrasound to measure the dilatations of the cardiac cavities at visit 1 and 2.

Transthoracic pulmonary ultrasound

Intervention Type DEVICE

The participants will have a transthoracic pulmonary ultrasound to quantify the presence of signs of pulmonary vascular overload (comet tails) at visit 1 and 2.

Blood collection

Intervention Type BIOLOGICAL

Several blood samples will be collected at visit 1 and 2.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Terrestrial exercise

At visit 1 (Day 0), an exercise test will be performed (maximal incremental test), followed by a 30-minute submaximal exercise at constant load.

During this exercise, continuous data collection will be performed:

* Continuous 12-lead electrocardiogram
* Continuous monitoring of blood pressure and ventilation.

Intervention Type OTHER

Swimming exercise

At visit 2 (Day 7), the subjects will perform a swimming exercise in the experimental pool equipped with a turbine to create a counter-current. The water speed will be constant (4 min per 100 m, i.e. 1.5 km/h). The duration of the exercise will be 30 minutes. Each diver will breathe with the help of a snorkel.

During this exercise, continuous data collection will be performed:

* Continuous 12-lead electrocardiogram
* Continuous monitoring of blood pressure and ventilation.

Intervention Type OTHER

Transthoracic cardiac ultrasound

The participants will have a transthoracic cardiac ultrasound to measure the dilatations of the cardiac cavities at visit 1 and 2.

Intervention Type DEVICE

Transthoracic pulmonary ultrasound

The participants will have a transthoracic pulmonary ultrasound to quantify the presence of signs of pulmonary vascular overload (comet tails) at visit 1 and 2.

Intervention Type DEVICE

Blood collection

Several blood samples will be collected at visit 1 and 2.

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Military or civilian diver with at least 100 dives
* Between the ages of 18 and 60
* Good physical condition (able to run/swim for 30 minutes at a constant pace).

Exclusion Criteria

* Divers with a current temporary medical incapacity to dive
* Persons with contraindications to physical exercise and/or scuba diving
* Pregnant or breastfeeding women
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Direction Centrale du Service de Santé des Armées

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Equipe Résidente de Recherche Subaquatique Opérationnelle

Toulon, , France

Site Status RECRUITING

Hôpital d'Instruction des Armées Sainte-Anne

Toulon, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

CASTAGNA Olivier, MD, PhD

Role: CONTACT

483162830 ext. +33

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Olivier CASTAGNA, MD, PhD

Role: primary

483162830 ext. +33

Jean-Eric BLATTEAU, MD, PhD

Role: primary

483162189 ext. +33

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021-A01225-36

Identifier Type: OTHER

Identifier Source: secondary_id

2019PBMD07

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.